Association between in-hospital changes in estimated plasma volume status and worsening renal function in patients with acute heart failure

Worsening renal function (WRF) during treatment for acute heart failure (AHF) has context-dependent clinical implications. Estimated plasma volume status (ePVS), calculated from hematocrit and body weight, may complement decongestion assessment. We evaluated the association between in-hospital change in ePVS (ΔePVS) and WRF. This single-center retrospective study included 309 adults hospitalized with AHF from 2021 to 2025. ΔePVS was defined as the last in-hospital ePVS minus admission ePVS; WRF was defined as an increase in serum creatinine of ≥ 26.5 µmol/L or ≥ 50%. Analyses included multivariable regression, bootstrap correction, and a 48-hour landmark analysis. Readmission analyses treated death as a competing event. WRF occurred in 92 patients (29.8%). ΔePVS was higher in patients with WRF than in those without WRF (1.0% vs. − 4.5%; P < 0.001). The adjusted odds ratio per 5% increase in ΔePVS was 1.54 (95% confidence interval [CI], 1.19–1.99). In sequential Firth models of 295 patients, the odds ratio was 1.39 (95% CI, 1.05–1.84) after adjustment for treatment intensity and diuretic response; the corresponding 48-hour landmark estimate was 1.36 (95% CI, 1.04–1.78). ΔePVS correlated modestly with changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP) and clinical congestion signs and was driven mainly by hematocrit change. Adding ΔePVS increased the apparent area under the receiver operating characteristic curve (AUC) by 0.016 ( P = 0.098). The WRF/ΔePVS ≥ 0 phenotype had a greater 90-day readmission risk than the no-WRF/ΔePVS < 0 phenotype (subdistribution hazard ratio [sHR], 3.84; 95% CI, 1.91–7.72). A smaller decrease or an increase in ePVS was associated with WRF, less hemoconcentration, and a poorer early diuretic response. ΔePVS may complement multimodal decongestion assessment; however, its incremental discriminative and prognostic value requires external validation.

Authors

Institutions

Publication Details

Journal
BMC Cardiovascular Disorders
Published
2026-09-25
DOI
https://doi.org/10.1186/s12872-026-06525-x
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Association between in-hospital changes in estimated plasma volume status and worsening renal function in patients with acute heart failure

Lu Gan, Kuo Wang, Zhihui Yuan, Simu Li et al.
BMC Cardiovascular Disorders
Heart Failure Treatment and Management
article

Association between in-hospital changes in estimated plasma volume status and worsening renal function in patients with acute heart failure

Lu Gan, Kuo Wang, Zhihui Yuan, Simu Li, Qiqi Jiang, Tian Xixi
article en

Abstract

Worsening renal function (WRF) during treatment for acute heart failure (AHF) has context-dependent clinical implications. Estimated plasma volume status (ePVS), calculated from hematocrit and body weight, may complement decongestion assessment. We evaluated the association between in-hospital change in ePVS (ΔePVS) and WRF. This single-center retrospective study included 309 adults hospitalized with AHF from 2021 to 2025. ΔePVS was defined as the last in-hospital ePVS minus admission ePVS; WRF was defined as an increase in serum creatinine of ≥ 26.5 µmol/L or ≥ 50%. Analyses included multivariable regression, bootstrap correction, and a 48-hour landmark analysis. Readmission analyses treated death as a competing event. WRF occurred in 92 patients (29.8%). ΔePVS was higher in patients with WRF than in those without WRF (1.0% vs. − 4.5%; P < 0.001). The adjusted odds ratio per 5% increase in ΔePVS was 1.54 (95% confidence interval [CI], 1.19–1.99). In sequential Firth models of 295 patients, the odds ratio was 1.39 (95% CI, 1.05–1.84) after adjustment for treatment intensity and diuretic response; the corresponding 48-hour landmark estimate was 1.36 (95% CI, 1.04–1.78). ΔePVS correlated modestly with changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP) and clinical congestion signs and was driven mainly by hematocrit change. Adding ΔePVS increased the apparent area under the receiver operating characteristic curve (AUC) by 0.016 ( P = 0.098). The WRF/ΔePVS ≥ 0 phenotype had a greater 90-day readmission risk than the no-WRF/ΔePVS < 0 phenotype (subdistribution hazard ratio [sHR], 3.84; 95% CI, 1.91–7.72). A smaller decrease or an increase in ePVS was associated with WRF, less hemoconcentration, and a poorer early diuretic response. ΔePVS may complement multimodal decongestion assessment; however, its incremental discriminative and prognostic value requires external validation.

BMC Cardiovascular Disorders
Sichuan University (CN), West China Hospital of Sichuan University (CN), Affiliated Hospital of Hebei University (CN)
Good health and well-being
Openalex Percentile: Top 11%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.